Securely connects you to portions of your medical record:
Online second opinions from top specialists:
Securely request a copy of your Images Studies from our Images Library:
Common Symptoms? MyCare Online allows you see a provider anywhere, anytime online or by mobile app.
Physician-to-physician medical record access:
Medical record system for physicians in private practice:
Find phone numbers and email addresses for Cleveland Clinic Online Services:
Enter the first letters of a doctor's last name.
Use filters to find the right specialist.
Use filters to find a doctor in a particular department.
Use filters to find any doctor at a particular facility.
Use filters to find a family doctor, internist or pediatrician.
Use filters to find a primary care pediatrician or pediatric specialist.
Print a directory listing of all physicians for each institute.
Request an Appointment
Contact us with Questions
Cancer Answer Line:
M-F 8 a.m. - 4:30 p.m. ET
The Department of Hematology & Medical Oncology is comprised of physicians, nurses, researchers, and other healthcare professionals specializing in the diagnosis and treatment of patients with cancers or disorders of the blood, solid organs, or soft tissues.
The department includes several programs devoted to specific disease or treatments such as chronic leukemia and multiple myeloma, blood and marrow transplantation, and palliative medicine.
The Acute Leukemia Program at Cleveland Clinic Taussig Cancer Institute is a worldwide leader in the treatment of acute myeloid and lymphoblastic leukemia. Patients are managed on a dedicated inpatient unit by a multidisciplinary team.
The Acute Leukemia Program features the most innovative treatments including several national studies for which Cleveland Clinic physicians serve as principal investigators. Patients benefit from both the special expertise of the program’s physicians and close collaboration with the Bone Marrow Transplant Program.
The department offers evaluation, treatment, and consultative services in the field of benign and malignant hematologic disorders. The benign areas include disorders of:
Dedicated to the diagnosis and treatment of patients with myelodysplastic syndromes (MDS), aplastic anemia, paroxysmal nocturnal hemoglobinuria, and other bone marrow failure conditions, the Bone Marrow Failure program has been recognized as a leader in pioneering diagnostic techniques and therapies by patient groups and national and international treatment and research organizations.
The Bone Marrow Failure program is led by nationally recognized physicians who work closely with specialty nurses and support staff to provide personalized, disease-directed care. .
Cleveland Clinic’s Bone Marrow Transplant Program is internationally recognized as a leader in the field. Autologous, allogeneic, non-myeloablative, bone marrow, peripheral stem cell and umbilical cord blood transplants are performed for patients with leukemias, lymphomas, and other hematological malignancies and bone marrow failure states.
As one of the most productive clinical research programs in the world, our physicians have performed over 3,000 bone marrow transplant procedures. Our large referral base and excellent community physician relationships allows for successful continuity of care, making us a leader among bone marrow transplant centers.
The Chronic Leukemia and Multiple Myeloma Program provides patients and physicians access to innovative treatment options, recognized medical expertise, and dedicated support resulting in superior outcomes.
These patients are evaluated and managed by a multidisciplinary team comprised of physicians, nurses and social workers. The program offers patients clinical trials of promising agents and works closely with the lab in developing new, innovative approaches to treatment.
Patient Referrals or Questions:
Cancer Answer Line
The better educated the patient and his or her family are about cancer usually results in a better outcome of therapy. A patient who understands the disease will tend to be able to identify problems sooner and is usually able to follow instructions better. The Taussig Cancer Institute provides a Multiple Myeloma Support Group as well as many additional patient support services to assist our patients in his or her time of need.
Cleveland Clinic Chronic Leukemia & Multiple Myeloma Program provides several informational brochures for our patients to review. Please feel free to contact the Cancer Answer Line with any questions or call us locally at 216.445.5008 or toll-free (866.223.8100).
The International Myeloma Foundation (IMF)
Toll-free (US & Canada): 800.452.CURE (2873)
Phone (Outside US & Canada): 818.487.7455
The Multiple Myeloma Research Foundation (MMRF)
The treatment of multiple myeloma had not changed the course of the disease significantly until the advent of novel therapies in the last 10 years. Now, many patients can expect long remissions and improved survival as a result of groundbreaking treatment advances. Therefore, we believe that active research and new treatment modalities are necessary to achieve our goals in controlling the disease for longer periods of time in even more patients.
Over the past few years a better understanding of the biology of the disease has resulted in a large flux of new promising agents that are being studied at Cleveland Clinic independently and/or in collaboration with other myeloma institutions in the US, Europe, Australia and Asia. This will allow for better treatments, and will hopefully translate into better quality of life and survival for myeloma patients.
Using a multidisciplinary approach to care with colleagues in the departments of nephrology, radiation oncology, orthopedic surgery and palliative medicine, patients at Cleveland Clinic will receive specialized care in hopes of superior outcomes.
The Cleveland Clinic Chronic Leukemia & Multiple Myeloma Research Program focuses on new drug development, as well as studying the tumor biology to modify its behavior. Over the past few years the research in the biology area has remarkably improved our understanding to develop less toxic and more rational maintenance therapy. Search our database for a listing of clinical trials available at the Taussig Cancer Institute.
Cleveland Clinic Chronic Leukemia & Multiple Myeloma Support and Education Group is designed to provide patients and families with a strong support network as well as educate the patient about his or her disease. It is our belief that a better-educated patient will have a greater chance of survival and a better experience during treatment.
The Lymphoma Program is a comprehensive, multidisciplinary effort dedicated to the diagnosis and treatment of Hodgkin and non-Hodgkin lymphoma; education and support of patients and their families; investigation of lymphoma pathobiology; and development of innovative treatments.
We review new patients and pathology specimens at a weekly multidisciplinary clinicopathology conference to ensure accurate diagnosis and determine the best available individualized management. In addition to standard treatments (e.g. chemotherapy, monoclonal antibodies, radioimmunoconjugates and hematopoietic stem cell transplantation), we also have available many novel agents such as monoclonal antibodies, vaccines, and targeted therapies.
Patients with a complex, life-threatening illness often have unrelieved cancer symptoms and significant physical difficulties sometime during their illness. Specially trained staff in the Harry R. Horvitz Center for Palliative Medicine at Cleveland Clinic Taussig Cancer Institute coordinate the complex medical care for patients as they face the physical and psychological challenges associated with their illness and the pain related to cancer symptoms.
If you are 75 or older and have been diagnosed with cancer, you may benefit from a specialized assessment at Taussig Cancer Institute's Geriatric Oncology Clinic. The assessment is designed to identify and manage problems related to a cancer diagnosis and treatment that may otherwise get overlooked. The assessment's goal is to improve your quality of life, offer reassurance to you and your family, and empower you to make informed health care decisions.
Results per page:
Location(s): Cleveland Clinic Main Campus
Department: Hematology and Oncology
Breast Cancer, Cancer, Cancer Supportive Care, Clinical Trials, Endocrine Treatment
Type of Doctor: Adults Only
Calicut Medical College
Cancer, Esophageal Cancer, Hypopharyngeal Cancer, Laryngeal Cancer, Nasal Cavity Cancer, Nasopharyngeal Cancer, Head and Neck Cancer
New York University School of Medicine
Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia, Aplastic Anemia, Cancer, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Leukemia
Duke University School of Medicine
Department: Brain Tumor and Neuro-Oncology Center
Adult Brain Tumors, Anaplastic Astrocytomas, Anaplastic Oligodendrogliomas, Astrocytoma, Benign Brain Tumors, Benign Tumors of the Brain, Benign Tumors of the Spinal Cord
Maulana Azad Medical College, University of Delhi
Breast Cancer, Cancer, Hematologic Malignancies, Clinical Trials, General Hematology, Bone Marrow Transplantation, Chemotherapy
University of Osteopathic Medicine and Health Sciences
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.
Monday through Friday from 8 a.m. – 4:30 p.m. (ET).
Resources for medical professionals
Search available cancer clinical trials by disease, hospital, phase or number.
This information is provided by Cleveland Clinic and is not intended to replace
the medical advice of your doctor or health care provider.
Please consult your health care provider for advice about a specific medical condition.
© Copyright 2015 Cleveland Clinic. All rights reserved.
Cleveland Clinic © 1995-2014. All Rights Reserved. 9500 Euclid Avenue, Cleveland, Ohio 44195 | 800.223.2273 | TTY 216.444.0261